Updates from The Motley Fool

Latest updates on Synta Pharmaceuticals Corp. from Fool.com.


Stock Performance

SNTA vs. S&P 500 | 2 Year Performance
SNTA 1-Day Stock Chart
SNTA 5-Day Stock Chart
SNTA 1-Month Stock Chart
SNTA 3-Month Stock Chart
SNTA 6-Month Stock Chart
SNTA 1-Year Stock Chart
SNTA 2-Year Stock Chart
SNTA 5-Year Stock Chart
View Interactive SNTA Charts
Sponsored by

Key Data Points

Primary metrics and data points about Synta Pharmaceuticals Corp..
Current Price: $0.40
Prev Close: $0.42
Open: $0.42
Bid: $0.38
Ask: $0.50
Day's Range: $0.39 - $0.44
52wk Range: $0.15 - $2.65
Volume: 937,734
Avg Vol 1,419,739
Market Cap: $55.12M
P/E (ttm): -0.79
EPS (ttm): -$0.53
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Synta Pharmaceuticals Corp..
CAPS Rating 2 out of 5
 
168 Outperform
31 Underperform
CAPS All Stars
 
24 Outperform
8 Underperform

How do you think Synta Pharmaceuticals Corp. will perform against the market?



You pick for Synta Pharmaceuticals Corp. is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Chen Schor, CEO

0% Approve

Based on 0 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Synta Pharmaceuticals Corp..

A biopharmaceutical company focused on discovering, developing and commercializing small molecule drugs that address severe medical conditions with potential markets, including cancer and chronic inflammatory diseases.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers